NewZ NewZ with a Zeal
A study in South Africa showed that two shots of Pfizer Inc. and BioNTech SE’s vaccine could offer 70% protection against hospitalization with the omicron variant. The World Health Organization said Africa experienced fewer deaths during the continent’s recent Covid surge.
